InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Ordentlich Peter, Directeur Scientifique. Officer active across 1 companies, notably Syndax Pharmaceuticals Inc. In total, 2 reports have been recorded. The latest transaction was disclosed on 31 January 2022 — J. Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€15,6871,412 shares@ €11.10970.0009% mcap50.0% of flow
Common Stock
SEC:0001562180-22-001079:0·
€15,6871,412 shares@ €11.10970.0009% mcap100.0% of flow
Common Stock
SEC:0001562180-22-001079·
2 of 2 declarations
About Ordentlich Peter
Peter Ordentlich is the Chief Scientific Officer at Syndax Pharmaceuticals Inc. He is responsible for leading the company's research and development initiatives, ensuring innovation and advancement in pharmaceutical technologies. Peter Ordentlich plays a key role in the scientific direction of the company, contributing to its success in the biopharmaceutical field.
